APOA1 and metabolic syndrome: Wu found APOA was significantly related to pancreatic adenocarcinoma.[24] However, it is difficult to tease out the specific mechanism responsible for the link between APOA levels and PDAC risk, but their research suggested that dyslipidemias may play a role in pancreatic tract carcinogenesis through their inflammatory properties.